Economic evaluation of the GENESIS-SEFH report of olaratumab with doxorubicin in soft tissue sarcoma in advanced stages
Objective: The economic evaluation of the drug olaratumab is carried out in the treatment of soft tissue sarcoma.Method: The data were analyzed following the recommendations contained in the MADRE program of the GENESIS-SEFH report model.Results: Progression free survival and overall survival res...
שמור ב:
| הוצא לאור ב: | Farmacia Hospitalaria |
|---|---|
| Principais autores: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Sociedad Española de Farmacia Hospitalaria
2018
|
| נושאים: | |
| גישה מקוונת: | https://www.redalyc.org/articulo.oa?id=365962347006 https://www.redalyc.org/journal/3659/365962347006/ https://www.redalyc.org/journal/3659/365962347006/html/ https://www.redalyc.org/journal/3659/365962347006/365962347006.epub https://www.redalyc.org/journal/3659/365962347006/movil |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|